Marker Therapeutics Inc (MRKR)

[microcapbiotech]

I have a few of questions for Phantom or anybody else. #1 Being that we just had a company vote on 6-6-23, and as I suspect that something did NOT just come up out of the blue that caused this CAO replacement, why not just do this before the 6-6 vote and avoid the "Annual Performance Bonus" as it would not have applied being it would have been less than 6 months of calendar year service?

#2 The new Interim CAO Eliot M. Lurier "receives no compensation directly from the Company" so he gets paid through the "Danforth Consulting Agreement". I am trying to figure out IF and how much money this will save us, if any. So, does anybody know the yearly cost of the "Danforth Consulting Agreement" versus the yearly cost of salary and compensations for the departing CAO? Also, is the "Danforth Consulting Agreement" also taking over the duties of the departed CFO Anthony Kim? And if so, the question would be the yearly cost of the "Danforth Consulting Agreement" versus the yearly costs of salaries and compensations for BOTH the departing CAO and CFO.

#3 Can anybody direct me as to where I can read the "Danforth Consulting Agreement" to see the costs, entailed responsibilities and obligations?

#4 I would like to believe that this CAO replacement will be addressed by Juan Vera as part of his upcoming Strategic Review. Is that a fair assumption or too much to ask?
Thank You